Skip to main content
. Author manuscript; available in PMC: 2015 May 14.
Published in final edited form as: Psychopharmacology (Berl). 2011 Jun 30;219(1):109–122. doi: 10.1007/s00213-011-2383-4

Table 2. Acute (day 1) amphetamine-related effects on subjective-effect ratings.

Drug conditions

Placebo 20 mg MA 40 mg MA 100 mg MDMA



Mean (SEM) Mean (SEM) F value Mean (SEM) F value Mean (SEM) F value
Peak physiological and “positive” subjective-effect ratings
Alert 28.0 (9.1) 55.3 (9.6) 18.2* 61.5 (9.2) 27.6* 34.6 (9.0) 10.4§
Blurred vision 0.0 (0.0) 3.2 (2.5) 1.1 6.5 (3.7) 4.7 27.2 (9.8) 81.8*§
Chills 0.0 (0.0) 1.7 (1.7) 0.3 2.1 (1.8) 0.5 17.7 (9.7) 32.3*§
Content 43.5 (10.5) 52.9 (9.0) 1.6 64.8 (10.0) 8.3* 49.4 (7.9) 0.6
Energetic 26.0 (8.9) 51.6 (8.5) 17.0* 53.3 (8.9) 19.3* 24.9 (7.6) 18.5§
Good drug effect 2.3 (2.3) 31.7 (10.3) 38.1* 55.8 (10.9) 125.9* 49.6 (11.6) 98.5*§
Heart pounding 2.9 (2.9) 16.8 (8.7) 13.2* 22.4 (10.4) 25.8* 20.9 (9.9) 22.1*
High 3.0 (2.7) 37.4 (10.1) 72.2* 51.9 (8.5) 146.2*§ 62.1 (10.8) 213.5*§
Social 38.6 (8.7) 57.2 (6.8) 12.8* 53.5 (7.8) 8.3* 41.2 (9.9) 9.5§
Stimulated 8.2 (4.1) 40.5 (8.6) 62.5* 54.4 (6.1) 127.4*§ 45.5 (11.1) 83.4*
Sweating 0.0 (0.0) 8.6 (5.0) 5.0 19.8 (9.0) 26.6*§ 32.3 (12.4) 70.4*§
Talkative 31.7 (10.5) 34.2 (10.8) 0.1 49.5 (8.5) 7.6*§ 27.5 (8.6) 11.6
Want cigarette 10.7 (5.2) 25.2 (11.0) 3.8 19.4 (7.9) 1.3 31.2 (10.9) 7.6*
Peak “negative” subjective-effect ratings
Bad drug effect 1.1 (1.1) 6.6 (4.8) 3.1 0.4 (0.4) 0.1 20.9 (8.4) 39.1*§
Can't concentrate 10.7 (8.0) 6.4 (6.0) 0.5 13.6 (6.7) 0.2 34.6 (10.4) 14.9*§
Clumsy 2.1 (1.8) 5.3 (4.7) 0.8 6.2 (5.8) 1.2 21.3 (9.6) 27.1*§
Confused 5.5 (3.2) 6.4 (6.1) 0.0 9.5 (6.4) 1.2 21.3 (8.9) 18.3*§
Dizzy 2.9 (2.9) 4.8 (4.0) 0.3 5.9 (5.2) 0.8 26.4 (11.1) 49.7*§
Jittery 1.6 (2.6) 13.8 (7.6) 13.9* 8.0 (3.8) 3.8 34.2 (10.0) 99.2*§
Nauseous 2.5 (2.1) 1.5 (1.5) 0.1 0.0 (0.0) 0.7 15.1 (8.2) 17.0*§
Restless 11.6 (7.2) 17.5 (9.2) 1.4 9.6 (6.9) 0.2 24.5 (10.9) 6.6*
Sedated 0.9 (0.9) 2.8 (2.5) 0.2 5.8 (5.8) 1.4 26.9 (10.5) 38.9*§
*

p<0.05, significantly different from placebo

§

p<0.05, significantly different from 20 mg MA

p<0.05, significantly different from 40 mg MA